Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Michael Szarek

Concepts (294)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Acute Coronary Syndrome
35
2024
267
6.160
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
40
2025
413
5.350
Why?
Antibodies, Monoclonal, Humanized
37
2025
755
4.190
Why?
Anticholesteremic Agents
22
2024
146
4.090
Why?
Cholesterol, LDL
39
2025
360
3.190
Why?
Lipoprotein(a)
16
2025
67
3.120
Why?
Peripheral Arterial Disease
14
2024
456
2.070
Why?
Glycosides
8
2025
37
2.010
Why?
Heptanoic Acids
20
2014
62
1.740
Why?
Cardiovascular Diseases
23
2025
1999
1.730
Why?
Stroke
14
2022
1063
1.690
Why?
Pyrroles
20
2014
191
1.620
Why?
Myocardial Infarction
17
2024
1015
1.620
Why?
Dyslipidemias
8
2025
176
1.480
Why?
Ischemic Attack, Transient
4
2020
60
1.440
Why?
Diabetes Mellitus, Type 2
15
2025
2430
1.270
Why?
Proprotein Convertase 9
14
2024
68
1.140
Why?
Treatment Outcome
52
2025
10152
1.140
Why?
Eicosapentaenoic Acid
2
2025
36
1.120
Why?
Platelet Aggregation Inhibitors
10
2024
440
1.030
Why?
Angina, Unstable
7
2019
77
1.020
Why?
Brain Ischemia
7
2022
305
0.960
Why?
Rivaroxaban
12
2024
253
0.960
Why?
Double-Blind Method
29
2025
1848
0.940
Why?
Hypertriglyceridemia
1
2024
39
0.880
Why?
Heart Failure
7
2024
2145
0.780
Why?
Antibodies, Monoclonal
5
2023
1355
0.780
Why?
Renal Insufficiency, Chronic
6
2025
561
0.740
Why?
Humans
109
2025
128418
0.660
Why?
Hypercholesterolemia
7
2020
101
0.640
Why?
Aged
57
2025
21953
0.630
Why?
Drug Therapy, Combination
13
2024
1009
0.630
Why?
Carcinoma, Renal Cell
1
2021
179
0.620
Why?
Lower Extremity
8
2022
402
0.620
Why?
Middle Aged
54
2025
30889
0.610
Why?
Patient Admission
1
2019
182
0.580
Why?
Simvastatin
4
2010
55
0.560
Why?
Kidney Neoplasms
1
2021
349
0.540
Why?
Aspirin
10
2024
376
0.490
Why?
Male
66
2025
62858
0.490
Why?
Female
65
2025
68154
0.460
Why?
Risk Factors
19
2024
9704
0.460
Why?
Patient Readmission
1
2019
664
0.440
Why?
Venous Thromboembolism
3
2023
271
0.440
Why?
Global Health
3
2021
327
0.430
Why?
Ischemia
5
2022
395
0.410
Why?
Life Change Events
1
2014
148
0.410
Why?
Secondary Prevention
5
2019
219
0.400
Why?
Triglycerides
3
2024
523
0.390
Why?
Serine Proteinase Inhibitors
3
2024
43
0.390
Why?
Career Choice
1
2014
209
0.380
Why?
Factor Xa Inhibitors
6
2024
169
0.380
Why?
Markov Chains
2
2010
116
0.380
Why?
Cholesterol
3
2022
406
0.340
Why?
Risk Assessment
8
2024
3232
0.330
Why?
Time Factors
10
2024
6482
0.330
Why?
Students, Medical
1
2014
315
0.320
Why?
Atherosclerosis
2
2024
403
0.320
Why?
Infectious Disease Transmission, Vertical
1
2010
170
0.310
Why?
Apolipoproteins B
6
2022
43
0.310
Why?
Coronary Disease
5
2009
382
0.310
Why?
Vascular Surgical Procedures
2
2021
293
0.300
Why?
Follow-Up Studies
8
2023
4892
0.290
Why?
Biomarkers
9
2025
3880
0.290
Why?
Endovascular Procedures
2
2022
302
0.290
Why?
Albuminuria
3
2024
181
0.270
Why?
Models, Statistical
1
2010
621
0.260
Why?
Randomized Controlled Trials as Topic
5
2024
1356
0.260
Why?
Cholesterol, HDL
4
2019
203
0.260
Why?
Proportional Hazards Models
9
2019
1196
0.250
Why?
Survival Analysis
1
2008
1263
0.240
Why?
Anticoagulants
4
2023
613
0.230
Why?
Hemorrhage
6
2024
645
0.230
Why?
Rosuvastatin Calcium
2
2022
20
0.230
Why?
HIV-1
1
2010
836
0.230
Why?
Internship and Residency
1
2014
1048
0.220
Why?
Primary Health Care
1
2014
1670
0.210
Why?
Glomerular Filtration Rate
2
2024
681
0.210
Why?
Fibrin Fibrinogen Degradation Products
1
2023
78
0.200
Why?
Antifibrinolytic Agents
1
2023
47
0.200
Why?
Hyperlipidemias
1
2003
126
0.200
Why?
RNA, Small Interfering
1
2024
571
0.200
Why?
Hospitalization
6
2023
2057
0.190
Why?
Blood Coagulation Disorders
1
2023
162
0.180
Why?
Muscles
1
2022
322
0.180
Why?
Cataract
1
2023
194
0.170
Why?
Phenylurea Compounds
1
2021
89
0.170
Why?
Quinolines
1
2021
153
0.170
Why?
Kidney Diseases
1
2023
367
0.170
Why?
Renal Insufficiency
1
2021
148
0.160
Why?
Health Status
1
2024
755
0.160
Why?
Colonic Neoplasms
1
2021
242
0.160
Why?
Patient Care Team
1
2024
605
0.160
Why?
Lipids
4
2010
620
0.150
Why?
Thrombosis
1
2022
324
0.150
Why?
Multifactorial Inheritance
1
2019
149
0.150
Why?
Venous Thrombosis
1
2020
161
0.150
Why?
Liver X Receptors
1
2018
30
0.150
Why?
Coronary Artery Bypass
1
2019
221
0.140
Why?
Apolipoproteins E
1
2018
78
0.140
Why?
Diabetes Complications
1
2019
223
0.140
Why?
Atrial Fibrillation
1
2022
377
0.140
Why?
Cost-Benefit Analysis
1
2020
568
0.140
Why?
Dose-Response Relationship, Drug
6
2021
1936
0.140
Why?
Neoplasms, Experimental
1
2018
169
0.140
Why?
Myeloid-Derived Suppressor Cells
1
2018
63
0.140
Why?
Prospective Studies
8
2022
7036
0.140
Why?
Diabetes Mellitus, Type 1
2
2023
3624
0.130
Why?
Myocardial Ischemia
3
2007
248
0.130
Why?
HIV Infections
1
2010
2701
0.120
Why?
Phospholipids
2
2009
207
0.120
Why?
Neoplasm Recurrence, Local
1
2021
958
0.120
Why?
Hospital Mortality
1
2019
844
0.120
Why?
Hypoglycemic Agents
4
2024
1212
0.120
Why?
Immunotherapy, Adoptive
1
2018
295
0.120
Why?
Killer Cells, Natural
1
2018
426
0.120
Why?
Proprotein Convertases
1
2014
15
0.120
Why?
Receptors, Interleukin-3
1
2014
5
0.110
Why?
C-Reactive Protein
3
2022
397
0.110
Why?
Colorectal Neoplasms
1
2021
746
0.110
Why?
Disease-Free Survival
2
2018
647
0.110
Why?
Adult
14
2023
35300
0.110
Why?
Antigens, Neoplasm
2
2006
309
0.110
Why?
Coronary Artery Disease
1
2019
678
0.100
Why?
Skin Neoplasms
2
2014
832
0.100
Why?
Neoplasms
2
2023
2464
0.100
Why?
Clinical Trials as Topic
3
2008
993
0.100
Why?
Hematologic Neoplasms
1
2014
139
0.100
Why?
Clinical Decision-Making
1
2015
304
0.100
Why?
Injections, Subcutaneous
2
2024
144
0.100
Why?
Developing Countries
1
2014
285
0.100
Why?
Immunity, Innate
1
2018
802
0.090
Why?
Diabetes Mellitus
1
2020
1000
0.090
Why?
Recombinant Fusion Proteins
1
2014
634
0.090
Why?
Leukemia, Myeloid, Acute
1
2018
591
0.090
Why?
Urban Population
1
2014
440
0.090
Why?
Heparin
2
2023
240
0.090
Why?
Sodium-Glucose Transporter 1
2
2020
10
0.090
Why?
Stroke Volume
2
2024
586
0.090
Why?
Dendritic Cells
1
2014
479
0.090
Why?
Bottle Feeding
1
2010
21
0.090
Why?
Norway
1
2010
42
0.090
Why?
Denmark
1
2010
44
0.090
Why?
Netherlands
1
2010
77
0.090
Why?
Finland
1
2010
90
0.090
Why?
Serum Amyloid A Protein
2
2007
30
0.090
Why?
Antineoplastic Agents
1
2021
2051
0.090
Why?
Sweden
1
2010
92
0.090
Why?
Likelihood Functions
1
2010
136
0.090
Why?
Arteries
2
2022
262
0.080
Why?
Risk
6
2008
853
0.080
Why?
Aged, 80 and over
7
2020
7033
0.080
Why?
Myocardial Revascularization
1
2009
69
0.080
Why?
Probability
1
2010
305
0.080
Why?
Statistics, Nonparametric
1
2010
418
0.080
Why?
Hydroxymethylglutaryl CoA Reductases
1
2009
14
0.080
Why?
Biomarkers, Tumor
2
2006
1181
0.080
Why?
Practice Guidelines as Topic
3
2019
1478
0.080
Why?
Melanoma
2
2006
752
0.080
Why?
United States Government Agencies
1
2008
6
0.080
Why?
Inflammation
4
2023
2654
0.070
Why?
Biometry
1
2008
69
0.070
Why?
Postoperative Complications
1
2019
2485
0.070
Why?
Tissue Plasminogen Activator
2
2022
219
0.070
Why?
Cell Line, Tumor
3
2021
3184
0.070
Why?
United States
3
2019
13830
0.070
Why?
Counseling
1
2010
382
0.070
Why?
Incidence
3
2022
2616
0.070
Why?
Recurrence
4
2019
996
0.070
Why?
Decision Making
1
2014
847
0.070
Why?
Fibrinolytic Agents
2
2022
246
0.070
Why?
Breast Feeding
1
2010
422
0.070
Why?
Data Interpretation, Statistical
1
2008
335
0.070
Why?
Reactive Oxygen Species
1
2009
577
0.070
Why?
Acute Disease
3
2021
964
0.060
Why?
Cancer Vaccines
1
2006
165
0.060
Why?
Lipoproteins, HDL
1
2005
85
0.060
Why?
Antigen-Antibody Complex
1
2004
84
0.060
Why?
CD40 Ligand
1
2004
38
0.060
Why?
Medication Adherence
1
2009
560
0.060
Why?
Lipoproteins, LDL
1
2004
126
0.060
Why?
Subtilisins
1
2023
10
0.050
Why?
Thromboplastin
1
2023
69
0.050
Why?
Ezetimibe
1
2022
26
0.050
Why?
Creatine Kinase
1
2022
74
0.050
Why?
Metabolic Syndrome
1
2005
338
0.050
Why?
Numbers Needed To Treat
1
2021
7
0.050
Why?
Plasma Membrane Neurotransmitter Transport Proteins
1
2021
4
0.050
Why?
Pharmacogenomic Testing
1
2022
60
0.050
Why?
Creatine
1
2021
55
0.050
Why?
Inflammation Mediators
1
2004
495
0.050
Why?
Goals
1
2022
160
0.050
Why?
Receptors, Immunologic
1
2022
209
0.040
Why?
Algorithms
1
2008
1618
0.040
Why?
Membrane Transport Proteins
1
2021
148
0.040
Why?
Diabetic Nephropathies
1
2024
278
0.040
Why?
Disease Progression
2
2024
2602
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
258
0.040
Why?
Mycoses
1
2020
69
0.040
Why?
Ventricular Function, Left
1
2023
524
0.040
Why?
Odds Ratio
3
2009
1023
0.040
Why?
Mice, Nude
1
2021
682
0.040
Why?
Diarrhea
1
2020
177
0.040
Why?
Hypotension
1
2020
113
0.040
Why?
Antigens, CD
1
2022
482
0.040
Why?
Age Factors
1
2007
3103
0.040
Why?
Propensity Score
1
2021
264
0.040
Why?
Patient Education as Topic
1
2024
737
0.040
Why?
Placebo Effect
1
2019
55
0.040
Why?
Sex Characteristics
1
2024
721
0.040
Why?
Sex Factors
1
2024
1945
0.040
Why?
Transplantation, Haploidentical
1
2018
21
0.040
Why?
Diabetic Ketoacidosis
1
2020
197
0.040
Why?
American Heart Association
1
2019
298
0.040
Why?
Nerve Tissue Proteins
1
2021
567
0.040
Why?
Cell Count
1
2018
313
0.030
Why?
Mice, SCID
1
2018
350
0.030
Why?
Erythrocytes
1
2022
672
0.030
Why?
Cohort Studies
2
2022
5388
0.030
Why?
Infant
1
2010
8914
0.030
Why?
Muscular Diseases
2
2008
108
0.030
Why?
Kidney
1
2024
1302
0.030
Why?
Vascular Diseases
1
2019
232
0.030
Why?
Liver
1
2024
1826
0.030
Why?
Morbidity
1
2017
301
0.030
Why?
Mice, Inbred NOD
1
2018
586
0.030
Why?
Apolipoproteins
2
2007
38
0.030
Why?
Membrane Proteins
1
2022
1105
0.030
Why?
Immunoglobulin M
2
2009
272
0.030
Why?
Genome-Wide Association Study
1
2022
1336
0.030
Why?
Cytoplasm
2
2006
257
0.030
Why?
Tissue Donors
1
2018
388
0.030
Why?
Cause of Death
1
2017
393
0.030
Why?
Xenograft Model Antitumor Assays
1
2018
814
0.030
Why?
Fluorobenzenes
1
2014
15
0.030
Why?
Interleukin-3
1
2014
24
0.030
Why?
Syndrome
2
2007
335
0.030
Why?
Thrombolytic Therapy
1
2015
130
0.030
Why?
Diphtheria Toxin
1
2014
64
0.030
Why?
Cell Proliferation
1
2021
2344
0.030
Why?
Serine Endopeptidases
1
2014
117
0.030
Why?
Oxidation-Reduction
2
2009
1001
0.030
Why?
Multivariate Analysis
2
2007
1484
0.030
Why?
Acute Kidney Injury
1
2020
773
0.030
Why?
Mice
2
2021
16602
0.030
Why?
Prognosis
3
2005
3772
0.030
Why?
Quality of Life
1
2024
2680
0.030
Why?
Immunoglobulin G
2
2009
843
0.030
Why?
Child, Preschool
2
2005
10384
0.030
Why?
Neoplasm Staging
2
2006
1290
0.020
Why?
CD8-Positive T-Lymphocytes
1
2018
846
0.020
Why?
Interleukin-6
2
2007
716
0.020
Why?
Adolescent
3
2006
20179
0.020
Why?
Molecular Targeted Therapy
1
2014
385
0.020
Why?
Mice, Knockout
1
2018
2755
0.020
Why?
Pyrimidines
1
2014
445
0.020
Why?
Predictive Value of Tests
2
2006
1935
0.020
Why?
Sulfonamides
1
2014
499
0.020
Why?
Mutation
1
2021
3689
0.020
Why?
Pilot Projects
1
2015
1564
0.020
Why?
Autoantibodies
2
2009
1463
0.020
Why?
Ireland
1
2008
27
0.020
Why?
Thromboembolism
1
2009
102
0.020
Why?
Apolipoprotein A-I
1
2008
28
0.020
Why?
Europe
1
2009
359
0.020
Why?
Lipoproteins
1
2009
171
0.020
Why?
United Kingdom
1
2008
257
0.020
Why?
Animals
2
2021
34479
0.020
Why?
Child
2
2005
20655
0.020
Why?
Drug Prescriptions
1
2009
248
0.020
Why?
Severity of Illness Index
1
2015
2722
0.020
Why?
Cerebral Infarction
1
2006
41
0.020
Why?
Gastrointestinal Diseases
1
2008
197
0.020
Why?
ROC Curve
1
2007
500
0.020
Why?
Hematuria
1
2005
12
0.020
Why?
Immunotherapy, Active
1
2005
9
0.020
Why?
Cerebral Hemorrhage
1
2006
106
0.020
Why?
Aspartate Aminotransferases
1
2005
85
0.020
Why?
Alanine Transaminase
1
2005
150
0.010
Why?
Apolipoprotein B-100
1
2004
10
0.010
Why?
Drug Utilization
1
2005
166
0.010
Why?
Drug Administration Schedule
1
2007
751
0.010
Why?
Arteriosclerosis
1
2004
88
0.010
Why?
Chemical and Drug Induced Liver Injury
1
2005
132
0.010
Why?
Angina Pectoris
1
2004
67
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
2006
815
0.010
Why?
Solubility
1
2004
229
0.010
Why?
Troponin
1
2003
50
0.010
Why?
Research Design
1
2009
1036
0.010
Why?
Databases, Factual
1
2008
1269
0.010
Why?
Heart Arrest
1
2004
310
0.010
Why?
Pain
1
2005
757
0.010
Why?
Retrospective Studies
2
2007
14454
0.010
Why?
Brain
1
2007
2620
0.010
Why?
Szarek's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)